Repligen | RGEN - SCHULD





SCHULD Veränderung Datum
Agilent USD 3.36B 1000K 2026-03
Align Technology USD 116.04M 1.6M 2026-03
Bio Techne USD 200M 0 2026-06
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Bruker USD 1.82B 153.5M 2026-06
Charles River Laboratories USD 3.06B 485.84M 2026-03
Danaher USD 26.48B 76M 2026-09
Dentsply International USD 2.33B 137M 2026-03
General Electric Aerospace USD 19.33B 169M 2026-09
Henry Schein USD 3.81B 64M 2026-06
Illumina USD 2.54B 9M 2026-03
IQVIA Holdings USD 16.24B 408M 2026-06
Mettler Toledo International USD 2.23B 76.47M 2026-03
Myriad Genetics USD 59.3M 19.7M 2025-03
OraSure Technologies USD 782K 465K 2024-06
Pacific Biosciences Of California USD 892.24M 653K 2023-12
Pfizer USD 63.19B 536M 2026-06
Repligen USD 690.94M 144.36M 2026-06
Revvity USD 3.35B 48.03M 2026-03
Standard Biotools USD 29.49M 2.1M 2026-03
Thermo Fisher Scientific USD 42.55B 612M 2026-06
Waters USD 5.57B 4.08B 2026-03
West Pharmaceutical Services USD 312.1M 109.3M 2026-06